Deploying our new SARS-CoV-2 serology test we found that higher antibody levels against COVID-19 are predictive of lower mortality and less organ dysfunction in acutely ill patients.
Check out our new publication:
Early increases in anti-SARS-CoV-2 antibody isotypes associated with organ dysfunction and mortality in patients hospitalized with COVID-19.
Best JR, Wang M, Lee T, Russell JA, DeMarco ML. Intensive Care Medicine. 2022; in press.